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Abstract Der3/Hrd1p is a protein required for proper degrada-
tion of misfolded soluble and integral membrane proteins in the
endoplasmic reticulum (ER) in the yeast Saccharomyces
cerevisiae. It is located to the ER membrane and consists of a
N-terminal hydrophobic region with several transmembrane
domains and a large hydrophilic tail oriented to the ER lumen
containing a RING finger motif of the H2 class. We had
previously reported that a truncated version of Der3p, Der3vRp,
lacking 111 residues of the lumenal domain including the RING
finger motif is not functional, suggesting the involvement of this
domain in the function of the protein in ER degradation. We
substantiated this hypothesis by constructing a mutated form of
Der3/Hrd1p replacing the last cysteine of the motif with a serine.
This mutated Der3C399S protein maintains the correct localiza-
tion and topology of the wild-type protein, however, is not able to
support the degradation of soluble and integral membrane
proteins. This point mutation altering the RING-H2 motif
behaves as a dominant allele especially when overexpressed from
a 2W plasmid by this increasing the half-life of CPY* more than
6-fold when compared with a wild-type strain. Furthermore co-
expression of der3C399S with the wild-type allele is also able to
partially suppress the temperature sensitive growth phenotype of
a sec61-2 strain. Finally we have shown that overexpression of
Hrd3p suppresses the dominant effect of the der3C399S mutation.
These results could be explained by a competition between wild-
type and mutant Der3 protein for the interaction with some other
component of the ER degradation pathway, probably Hrd3p.
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1. Introduction
The endoplasmic reticulum (ER) is the ¢rst organelle in the
secretory pathway of all eukaryotic cells which is passed by
plasma membrane, vacuolar, lysosomal and secretory proteins
to their port of destination [1]. To ensure the delivery of only
properly folded proteins to their site of action, a quality-con-
trol system operates in the ER, which is able to detect mal-
folded polypeptides or unassembled subunits of oligomeric
proteins and block their further transport to the Golgi [2].
Misfolded proteins retained in the ER are ¢nally transported
back to the cytosol through a Sec61p containing channel [3,4],
where they are degraded by the ubiquitin-proteasome system
associated with the cytoplasmic face of the ER membrane
[5,6]. Substrates for ER degradation include mutant forms
of proteins responsible for severe diseases such as cystic ¢bro-
sis, pulmonary emphysema or Wilson’s disease [7^9]. Also
some viral proteins are able to induce abnormal degradation
in the ER of proteins required for the immune response by
this increasing the virulence of infection by HIV type I or
human cytomegalovirus [10,11].
In the yeast Saccharomyces cerevisiae some components of
the ER degradation pathway have been identi¢ed. Compo-
nents of the import and folding machinery, Sec61p, Sec63p
and Kar2p are also required for the retrograde transport of
proteins to the cytosol [3,6]. Ubc6, Ubc7/Der2p and Cue1p
are responsible for polyubiquitination of the substrate [5,6,12]
and Rpn1p and other subunits of the 26S proteasome are
necessary for degradation of the ER proteins in the cytosol
[5,13].The function of three newly identi¢ed components of
the ER membrane, Der1p, Der3/Hrd1p and Hrd3p, remained
unknown [13^15].
Der3/Hrd1 is a protein required for ER degradation of a
wide variety of proteins including misfolded lumenal CPY*
[15] and integral membrane proteins, as are Sec61-2p [15],
HMG-CoA reductase [13] and Pdr5* [16]. The protein exhib-
its a N-terminal domain with ¢ve putative transmembrane
domains and a large hydrophilic tail oriented to the ER lumen
containing a RING-H2 ¢nger motif [15].
A RING-H2 ¢nger domain is de¢ned by the position and
distance between six cysteines and two histidines and is able to
bind two zinc atoms [17]. This class of motifs can be widely
found in otherwise non-related families of yeast and mamma-
lian proteins. In yeast, the RING-H2 domain of Ste5 plays a
crucial role in Ste4-promoted oligomerization of the protein
required for the pheromone response pathway [18] and a
RING ¢nger protein complex has been described as being
essential in protein transport to the vacuole [19]. Recently
the RING ¢nger domain of the Vmw 110 protein of the her-
pes simplex virus type I has been shown to be essential for
inducing degradation of the catalytic subunit of DNA-de-
pendent protein kinase by the proteasome pathway [20].
We had previously shown that the integrity of the lumenal
domain of Der3/Hrd1p is absolutely necessary for proper
function of the ER degradation pathway [15]. Here we have
constructed a point-mutated form of Der3/Hrd1p by eliminat-
ing one of the cysteine residues to demonstrate that the
RING-H2 domain is essential for the activity of the protein
and for unraveling genetic interactions with other components
of the ER degradation system.
2. Materials and methods
2.1. Strains and growth conditions
Saccharomyces cerevisiae isogenic strains W303-1C (MATK prc1-1
ade2-1 his3-11,15 leu2-3,112 trp1-1) [14], W303-1Cv3 (MATK prc1-1
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Fig. 1. Structure and localization of the Der3C399S mutant protein.
A: The RING-H2 ¢nger motif of Der3p. To construct the der3C399S
mutant allele, Cys399 was replaced by a serine residue. B: Steady-
state levels of Der3p and Der3C399Sp were measured by Western
blotting in yeast cells from strains W303-1C (DER3), W303-1Cv3
(vder3) and W303-1Cv3 carrying the der3c399s allele on a centro-
meric plasmid (der3c339s). C: Der3C399S protein is localized in ER
like structures. Yeast cells from strain W303-1Cv3 carrying the 2W
plasmid pRS/der3C399S were stained with polyclonal anti-Der3 anti-
bodies and goat anti-rabbit Cy3 antibody (Cy3) and 4,6-diamidino-
2-phenylindole (DAPI); DIC: Nomarski optics. D: The C-terminal
tail of Der3c399Sp remains oriented to the ER lumen. Yeast spher-
oplasts of the strain W303-1Cv3 carrying the centromeric plasmid
YCp/der3C399S were gently lysed and centrifugated to separate a
soluble fraction (SN) from the pellet fraction (P) containing intact
yeast microsomes. Aliquots of microsomes were incubated for
30 min on ice in the absence (3) or in the presence of trypsin (+T)
or trypsin and Triton X-100 (T+X). After TCA precipitation pellets
were resuspended in a urea bu¡er, immunoblotted after SDS-PAGE
and stained with anti-Der3p or anti-CPY polyclonal antibodies.
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Fig. 2. Der3C399S mutant protein is not able to support ER degrada-
tion. A: Steady-state levels of CPY* in crude extracts prepared
from early stationary phase yeast cells grown on CM medium of
the strains W303-1C (WT), W303-1Cv3 (vder3) and W303-1Cv3
carrying the der3C399S allele in a centromeric plasmid (vder3 YCp/
der3C399S) were measured after Western blotting. B: The der3C399S
mutant allele is not able to complement the suppression of the tem-
perature sensitive growth phenotype of a sec61-2 vder3 strain.
Strain W303-1C (WT), YRP086 (sec61-2) and YRP105 (sec61-2
vder3) harboring the LEU2 containing plasmid YCplac111 and
YRP105 (sec61-2 vder3 YCp/der3C399S) carrying the der3C399S allele
on a centromeric plasmid were tested for growth at 30‡C and 38‡C
on CM plates without leucine for 48 h.
s
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ade2-1 his3-11,15 leu2-3,112 trp1-1 der3: :HIS3) [15], YRP086 (MATK
prc1-1 ade2-1 his3-11,15 leu2-3,112 trp1-1 sec61-2) [3] and YRP105
(MATK prc1-1 ade2-1 his3-11,15 leu2-3,112 trp1-1 sec61-2 der3: :
HIS3) [3] were grown on CM media [21] at 30‡C unless otherwise
indicated.
2.2. Molecular biological techniques, site-directed mutagenesis and
plasmid construction
Standard techniques of molecular biology have been previously
described [22].
The der3C399S allele was constructed using the ‘megaprimer’ method
[23]. The ¢rst round of PCR was performed with the primers 5P-
ATCTTGGCACTATATCAA-3P and 5P-CAATCTAGAAATAGGA-
CA-3P (whereby G in bold replaces a C from the wild-type gene) using
as a template the plasmid pUC/DER3 [15]. For the second round the
product of the ¢rst PCR reaction, digested with EcoRV and puri¢ed
and the universal primer were used as primers. Conditions for both
reactions have been previously described [23]. The ¢nal product of the
reaction was digested with EcoRI and subcloned into the plasmid
pUC/DER3 digested with EcoRI and EcoRV yielding the plasmid
pUC/der3C399S. The correctness of the recombinant clones containing
the point mutation was checked by DNA sequencing. Plasmids YCp/
der3C399S and pRS/derC399S were obtained by subcloning an EcoRI-
HindIII fragment from pUC/derC399S into YCplac111 and pRS426
respectively.
2.3. Antibodies, Western blotting, immuno£uorescence and pulse-chase
experiments
Polyclonal anti-Der3p [15] was diluted 1:2500 for Western blotting
and 1:250 for immuno£uorescence. Monoclonal anti-CPY (Molecular
Probes) was diluted 1:10 000 for Western blotting. Western blotting
and immunodetection of CPY* and Der3p, immuno£uorescence for
intracellular localization of the Der3C399S protein, protease protection
and pulse-chase experiments were performed as previously described
[15].
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Fig. 3. Dosage-dependent dominance of der3 mutant alleles a¡ecting the RING-H2 motif region. A: Steady-state levels of CPY* in crude ex-
tracts prepared from strain W303-1C (WT) not expressing (3) or expressing der3C399S or der3vR from a centromeric (CEN) or a multicopy
(2W) plasmid and strain W303-1Cv3 grown on CM medium were immunodetected with monoclonal anti-CPY antibodies after SDS-PAGE and
Western blotting. B, C: Kinetics of degradation of CPY*. A pulse-chase experiment was performed using strain W303-1C (WT), W303-1C har-
boring the der3C399S allele on a multicopy plasmid (WT/der3C399S 2W) and strain W303-1Cv3. Exponentially growing cells on CM medium were
labeled with [35S]methionine as previously described [15]. After the chase aliquots of cells were taken at the indicated chase points and immuno-
precipitated with polyclonal anti-CPY antibodies. Kinetics of CPY* degradation was measured using a Molecular Dynamics imaging system.
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3. Results and discussion
We have constructed a mutant form of Der3/Hrd1p by
replacing the last cysteine (Cys-399) of the RING-H2 ¢nger
domain by a serine (Fig. 1A). This mutant protein called
Der3C399S was expressed in a vder3 null mutant strain from
a centromeric plasmid. Steady-state levels of the mutant pro-
tein were checked by Western blotting and immunodetection
with anti-Der3 antibodies. As can be seen in Fig. 1B,
Der3C399Sp can be easily detected as a single band with the
same electrophoretic mobility and intensity than the Der3
wild-type protein. To con¢rm the correct intracellular local-
ization of Der3C399S protein, we performed immuno£uores-
cence with anti-Der3 antibodies in intact yeast cells from a
strain expressing the mutant allele from a multicopy plasmid.
As we have previously described for wild-type Der3p [15], a
typical ER staining, perinuclear with some staining regions
along the plasma membrane can be observed (Fig. 1C). We
had reported that the C-terminal hydrophilic tail of Der3/
Hrd1p is oriented to the ER lumen [15]. In order to con¢rm
that this topology is not changed in the Der3c399S mutant
protein, a protease protection experiment using isolated mi-
crosomes was performed (Fig. 1D). Der3C399Sp can be de-
tected in the microsomes containing fraction (P) even in the
presence of trypsin (+T) and only after adding a detergent
(+T+X) the protein is accessible to the protease and is ¢nally
degraded. This result con¢rmed the lumenal orientation of the
C-terminal domain of Der3c399Sp.
We investigated whether Der3c399Sp is able to support
degradation of misfolded lumenal and integral membrane pro-
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Fig. 4. Overexpression of der3 mutant alleles afecting the RING-H2 domain partially suppresses the temperature sensitive growth phenotype of
the sec61-2 mutant. Strain W303-1C (WT) and YRP086 (sec61-2) harboring the URA3-based plasmid pRS426 and strain YRP086 expressing
the der3C399S (sec61-2 der3C399S 2W) or the der3vR (sec61-2 der3vR 2W) from a multicopy plasmid were tested for growth on CM plates at 30‡C
and 38‡C for 72 h.
Fig. 5. Overexpression of the HRD3 gene can partially revert the dominant e¡ect of the der3c399s mutation. Strain W303-1C (WT) and
YRP086 (sec61-2) carrying plasmids pRS426 and YCplac111, and YRP086 expressing HRD3 from a multicopy plasmid (sec61-2 2W HRD3) or
der3C399S from a centromeric plasmid (sec61-2 CEN der3C399S ) or both (sec61-2 2W HRD3 CEN der3C399S ) were grown on CM plates without
leucine and uracil at 30‡C and 37‡C for 72 h.
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teins of the ER. As example of a lumenal substrate, we meas-
ured steady-state levels of CPY* by Western blotting in yeast
strains carrying DER3 wild-type and mutant alleles. We found
similar accumulation of CPY* in a der3C399S and a vder3 null
mutant strains (Fig. 2A). The sec61-2 allele encodes a mutant
form of the Sec61 protein, the major component of the pro-
tein import machinery of the ER. The sec61-2 allele encoded
protein at the restrictive temperature of 38‡C is degraded by
the 26S proteasome, leading to a temperature sensitive growth
phenotype of cells [24]. We have described previously that this
phenotype can be suppressed by a deletion of the DER3/
HRD1 gene [15]. As is shown in Fig. 2B this suppression
cannot be reverted by the der3C399S allele. Thus, the RING-
H2 ¢nger domain is essential for the function of Der3p in ER
associated degradation.
The RING-H2 ¢nger domain of the Ste5 protein is required
for interaction with Ste4 and subsequent oligomerization of
the protein [18]. The RING-H2 ¢nger domain of Der3p could
play a similar role and mediate interactions with additional
components of the ER degradation pathway. In order to in-
vestigate putative proteins interacting with Der3p through its
RING ¢nger motif, we used the der3vR and der3C399S mutant
alleles as tools. As can be seen in Fig. 3A, co-expression of
mutant and wild-type alleles leads to an increase in steady-
state levels of CPY* due to a partial block of its degradation.
This increase is more prominent in the case of the der3C399S
point mutation and is dosage-dependent. Accumulation of
CPY* is higher after overexpression of mutant alleles from
multicopy plasmids as compared to expression on a CEN-
plasmid (Fig. 3A). We have previously shown that DER3 is
able to support degradation of CPY* and Sec61-2p, even
when expressed under the control of the GAL promoter
[15]. In order to quantify the dominant e¡ect of the der3c399s
allele expressed from a 2W plasmid on CPY* degradation over
wild-type, we performed a pulse-chase experiment. As can be
seen in Fig. 3B,C, the half-life of CPY* is increased by about
6-fold upon expression of the der3C399S in the wild-type back-
ground as compared to the corresponding strain carrying only
the DER3 wild-type allele. Not surprisingly co-expression of
the der3C399S or the der3vR allele on a multicopy plasmid
(Fig. 4) or a centromeric plasmid (not shown) in a DER3
wild-type partially suppresses the temperature sensitive
growth phenotype exerted by a mutated Sec61 protein (allele
sec61-2).
Dosage-dependent dominance of the der3C399S allele can be
explained by a competition between the wild-type and the
mutant Der3 protein in the interaction with either itself or
with some other component of the ER degradation pathway.
The formation of non-functional hybrid dimers of wild-type
and mutant molecules of Der3p could lead to the observed
phenotype. We constructed a mutant form of Der3p in which
the RING-H2 ¢nger region was replaced by the oligomeriza-
tion domain of glutathione S-transferase. However, this hy-
brid is not functional, suggesting that the RING-H2 ¢nger
domain is not involved in a putative dimerization of Der3p
required for the function of the protein (data not shown). On
the contrary, we found that overexpression of HRD3, another
gene involved in ER degradation [13], is able to revert the
dominance of der3C399S . As can be seen in Fig. 5, suppression
of the temperature sensitive growth phenotype of a sec61-2
strain co-expressing both wild-type and mutant Der3p can be
partially complemented after transformation with a multicopy
plasmid carrying the HRD3 gene.
We are currently investigating genetic and biochemical in-
teractions of Der3p with Hrd3p and other components in
order to explain their function in the ER degradation path-
way.
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